Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-008275)

Filing Details

Accession Number:: 0001415889-25-008275
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-17 21:05:47
Reporting Period:: 2025-03-13

Filing Date:: 2025-03-17
Accepted Time:: 2025-03-17 21:05:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1933414	Mineralys Therapeutics Inc.	MLYS	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1699737	Samsara Biocapital, L.p.	628 Middlefield Road Palo Alto CA 94301		No	No	Yes	No
1888829	Samsara Biocapital Gp, Llc	628 Middlefield Road Palo Alto CA 94301		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-13	600,000	$13.50	5,674,916	No	4	P	Indirect	By Samsara BioCapital, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Samsara BioCapital, L.P.

Footnotes

Securities are directly held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.